KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,000 | 0.0% | 282 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 282 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 282 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -50.0% | 282 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 282 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 282 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | 0.0% | 282 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | +100.0% | 282 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | -50.0% | 282 | 0.0% | 0.00% | -100.0% |
| Q2 2016 | $2,000 | +100.0% | 282 | +122.0% | 0.00% | – |
| Q2 2015 | $1,000 | – | 127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |